Back Talk

Who's calling who "murky"?

Who's calling who "murky"?

Once we venerated doctors. Now we question every dollar they make

Give docs a shot in the arm

Give docs a shot in the arm

Is there anything that pharma can do to make doctors' lives easier?

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Pharma's role in cost control

Pharma's role in cost control

It may be time to adopt a model in which we help deliver healthcare

Think you own your brand? Think again

Think you own your brand? Think again

When you have a successful brand, you tamper with it at your peril

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Making medicine emotional

Making medicine emotional

We identify not with just the product, but with what it represents

Popping the digital bubble

Popping the digital bubble

A general consensus is that a "shake-up" of some kind is coming

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.

Putting moves on Big Data

Putting moves on Big Data

It's time to make healthcare data Big, and for patients' sake, sexy


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.

Email Newsletters